Announcement of Selection as a J-Startup KANSAI Company

We are pleased to announce that our company has been selected for J-Startup KANSAI, a support program dedicated to identifying and fostering high-potential startups originating from the Kansai region.

As a research-driven startup in the fields of biotechnology and regenerative medicine, we are engaged in activities spanning from fundamental research to preclinical and clinical development, as well as business development with a view toward real-world implementation and societal impact.

Through the various forms of support and networks provided by this program, we aim to further enhance our research and development capabilities and accelerate commercialization efforts. By doing so, we will continue to contribute to solving critical medical challenges and to the realization of sustainable healthcare.
We sincerely appreciate your continued support and guidance.

https://www.kansai.meti.go.jp/3-3shinki/Startup/J-Startup/news/jsk_sentei2025.html